Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

A transaction for Springworks would rank as one of the biggest pharma deals for Merck in recent years and boost its ongoing ...

After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley ...

This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

Merck KGaA, the German healthcare and technology conglomerate, has announced that it is in advanced negotiations to acquire ...

As a sixth-generation farmer, Hueneke Martens brings a holistic perspective to food and agriculture, always advocating for ...

Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...